> The swine flu program was not a public health success. The vaccine was successfully manufactured, distributed, and administered to over 45 million people in a relatively short period of time—a considerable administrative and logistical achievement. However, the virus did not reappear the following winter, for reasons that no one understands. Furthermore, it appeared that 1 out of 100,000 of the recipients developed Guillain-Barré syndrome (the most recent study reports a rate of 1 per 200,000)8, an unexpected and unique occurrence of unknown etiology. As a result of the publicity about si…